Chinese pharmaceutical firms are plunging as a drug safety scandal spills over to become a sector-wide trust crisis. July 23, 2018 10:08 am by IWB Authorities found Changsheng Biotechnology’s subsidiary produced substandard vaccines and forged production data. Its shares have been suspended from trading.
